Top Vaccines companies in Denmark by Net Cash Used Provided By Financing Activities

This ranking features the top 6 Vaccines companies in Denmark ranked by Net Cash Used Provided By Financing Activities, totaling a Net Cash Used Provided By Financing Activities of USD -8.94 B, for February 06, 2025.
#
Name
Net Cash Used Provided By Financing Activities
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 148.22 M
Dec. 31, 2023 USD 130.66 2.64%

Denmark

2
USD 134.26 M
Dec. 31, 2023 USD 102.45 7.03%

Denmark

3
USD 108.92 M
Dec. 31, 2023 USD 24.06 1.57%

Denmark

4
USD 10.69 M
Dec. 31, 2023 USD 2.46 -0.40%

Denmark

5
USD 4.72 M
Dec. 31, 2023 USD 2.73 4.48%

Denmark

6
USD -9.35 B
Dec. 31, 2023 USD 86.17 4.52%

Denmark

Frequently Asked Questions
  • Which Vaccines company in Denmark has the highest Net Cash Used Provided By Financing Activities ?

    The Vaccines company in Denmark with the highest Net Cash Used Provided By Financing Activities is Ascendis Pharma A/S (NasdaqGS: ASND) at USD 148.22 M.

  • Which Vaccines company in Denmark has the lowest Net Cash Used Provided By Financing Activities ?

    The Vaccines company in Denmark with the lowest Net Cash Used Provided By Financing Activities is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD -9.35 B.

SV Wall Street